Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients
NCT06364072
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
155
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Interventions
DRUG:
CT001
Sponsor
Cessatech A/S